patients with recurrent acute myelogenous leukemia after transplantation
Showing 1 - 1 of 1
Patients With Recurrent Acute Myelogenous Leukemia After Transplantation Trial in Suzhou (CD47 mAb)
Recruiting
- Patients With Recurrent Acute Myelogenous Leukemia After Transplantation
- CD47 monoclonal antibody
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Mar 3, 2022